Rti Surgical Holdings Inc Receivables Turnover Ratio (RTIX), from the fourth quarter 2018 to the fourth quarter 2017 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rti Surgical Holdings Inc   (NASDAQ: RTIX)
 

Rti Surgical Holdings Inc Accounts Receivables Turnover Ratio from the fourth quarter 2018 to the fourth quarter 2017

Quarterly Results, Trends, Rankings, Statistics


Rti Surgical Holdings Inc 's ability to collect accounts receivable sequentially worsen to 6.25, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Rti Surgical Holdings Inc 's Accounts Receivable average collection period in the Dec 31 2018 quarter, has increased to 58 days, from 54 days, in the Sep 30 2018 quarter.

If we take a look into Healthcare sector 302 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to , from overall ranking in the third quarter 2018 at 2788.

What is Receivable Turnover Ratio?
What is Rti Surgical Holdings Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RTIX Receivables Turnover Ratio (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Receivable Change 37.83 % 21.98 % 16.57 % 14.6 % -15.44 %
Y / Y Revenue Change 0.56 % 3.56 % -1.99 % -0.07 % -0.74 %
Receivable Turnover Ratio (TTM) 6.25 6.74 7.02 7.36 7.62
RTIX's Total Ranking # # 2788 # 2352 # 2276 # 2140
Accounts Receivable average collection period days 58 54 52 50 48
Seq. Receivable Change 9.54 % -3.15 % 9.57 % 18.57 % -3.06 %
Seq. Revenue Change 3.12 % -2.29 % 1.14 % -1.31 % 6.19 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 303
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
8.59 7.28 6.12
(Jun 30 2012)   (Dec 31 2018)





RTIX Company Profile • Back to RTIX Efficiency Comparisons • Compare RTIX Receivables Turnover Ratio to its Competitors

Financial Statements
Rti Surgical Holdings Inc 's Accounts Receivable $ 48 Millions Visit RTIX's Balance sheet
Rti Surgical Holdings Inc 's Sales TTM $ 281 Millions Visit RTIX's Income Statement
Sources of RTIX's Revenues Visit RTIX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RTIX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RTIX's Growth Rates RTIX's Roa RTIX's Inventory Turnover Ratio RTIX's Dividend Comparisons
RTIX's Profitability Ratios RTIX's Roi RTIX's Asset Turnover Ratio RTIX's Dividend Growth
RTIX's Valuation Ratios RTIX's Roe RTIX's Financial Strength Ratios RTIX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2018 Receivable at quarter ending Dec 31 2018
Akebia Therapeutics Inc   15.58 $ 207.742  Millions$ 13.334  Millions
Chemed Corporation  15.53 $ 1,782.648  Millions$ 114.760  Millions
Endonovo Therapeutics Inc   14.46 $ 0.083  Millions$ 0.006  Millions
Lexicon Pharmaceuticals Inc   14.19 $ 62.887  Millions$ 4.431  Millions
Scienture Holdings Inc   14.12 $ 3.832  Millions$ 0.271  Millions
Mersana Therapeutics inc   14.06 $ 10.594  Millions$ 0.754  Millions
Regeneron Pharmaceuticals Inc   13.82 $ 6,818.149  Millions$ 493.407  Millions
Dmk Pharmaceuticals Corporation  13.18 $ 15.087  Millions$ 1.144  Millions
Emmaus Life Sciences Inc   13.10 $ 1.581  Millions$ 0.121  Millions
Creative Medical Technology Holdings Inc   13.09 $ 0.124  Millions$ 0.010  Millions
Puma Biotechnology Inc   12.84 $ 250.991  Millions$ 19.544  Millions
Wearable Health Solutions, Inc.  12.68 $ 0.855  Millions$ 0.067  Millions
Fate Therapeutics Inc   12.64 $ 4.740  Millions$ 0.375  Millions
Zeo Scientifix Inc   12.60 $ 0.723  Millions$ 0.057  Millions
Travere Therapeutics Inc   12.33 $ 164.246  Millions$ 13.324  Millions
La Jolla Pharmaceutical Company  12.23 $ 10.056  Millions$ 0.823  Millions
Integrated Biopharma Inc  12.21 $ 45.445  Millions$ 3.723  Millions
Corcept Therapeutics Inc  12.12 $ 251.247  Millions$ 20.728  Millions
Teladoc Health Inc   12.08 $ 460.219  Millions$ 38.084  Millions
Neurometrix Inc   11.91 $ 16.090  Millions$ 1.351  Millions
Vystar Corporation  11.72 $ 0.342  Millions$ 0.029  Millions
Exact Sciences Corporation  11.58 $ 454.462  Millions$ 39.250  Millions
Ensign Group Inc  11.57 $ 3,029.179  Millions$ 261.776  Millions
Five Prime Therapeutics Inc   11.49 $ 49.115  Millions$ 4.273  Millions
Plx Pharma Inc   11.44 $ 0.753  Millions$ 0.066  Millions
Zynex inc   11.38 $ 31.917  Millions$ 2.805  Millions
Procyon Corporation  11.33 $ 4.177  Millions$ 0.369  Millions
Immucell Corporation  11.18 $ 10.537  Millions$ 0.943  Millions
Durect Corp  11.17 $ 18.564  Millions$ 1.662  Millions
Redhill Biopharma Ltd   11.16 $ 8.360  Millions$ 0.749  Millions

Date modified: 2026-08-31T16:42:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.